February 16, 2015 by Brad Perriello
ViewRay last week said it plans to raise up to $69 million in an initial public offering for its MRIdian system, which it bills as "the 1st and only MRI-guided radiation therapy system that images and treats cancer patients simultaneously."
Oakwood Village, Ohio-based ViewRay’s MRIdian uses magnetic resonance imaging and Cobalt-60 radiation therapy to “locate, target and track the position and shape of soft-tissue tumors while radiation is delivered,” according to the IPO filing. Read more
February 13, 2015 by Brad Perriello
Bellerophon Therapeutics priced its initial public offering under range today but offered more shares than planned, for total proceeds of $60 million.
Hampton, N.J.-based Bellerophon had planned to raise up to $69 million by putting up 4 million shares at $14 to $16, but wound up floating 5 million shares at $12 apiece. Read more
February 19, 2015 by Val Kennedy
Cutera’s board of directors has expanded the company’s stock buyback plan from $10 million to $40 million, the company announced Wednesday.
The laser device-maker said it plans to begin repurchasing stock around Feb. 23. The company is under no obligation to acquire any particular number of shares. Read more
DeviceTalks Minnesota's leadership track is designed to provide attendees with insights on topics such as:
Use code SAVE15 to save 15%!